Last reviewed · How we verify
Uritos (IMIDAFENACIN)
Uritos (generic name: IMIDAFENACIN) is a drug. It is currently FDA-approved for Bladder muscle dysfunction - overactive.
Uritos is a small molecule that acts as a muscarinic acetylcholine receptor M3 antagonist. It is used to treat overactive bladder, as indicated by clinical trials comparing its efficacy and safety to Urotol.
At a glance
| Generic name | IMIDAFENACIN |
|---|---|
| Target | Muscarinic acetylcholine receptor M3 |
| Modality | Small molecule |
| Therapeutic area | Urology |
| Phase | FDA-approved |
Approved indications
- Bladder muscle dysfunction - overactive
Common side effects
Key clinical trials
- Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron. (PHASE4)
- Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
- A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
- Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder. (PHASE3)
- Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan (PHASE2)
- Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan (PHASE3)
- Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder (PHASE3)
- Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Uritos CI brief — competitive landscape report
- Uritos updates RSS · CI watch RSS
Frequently asked questions about Uritos
What is Uritos?
What is Uritos used for?
What is the generic name of Uritos?
What development phase is Uritos in?
What does Uritos target?
Related
- Target: All drugs targeting Muscarinic acetylcholine receptor M3
- Therapeutic area: All drugs in Urology
- Indication: Drugs for Bladder muscle dysfunction - overactive
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing